Tayyaba Riaz Bashir, M.D.
Hematology & Oncology Physician · New York, NY
Tayyaba Riaz Bashir, M.D. is a hematology & oncology physician with a practice address in New York, New York, and NPI 1528261351, issued on Jun 8, 2007. Check the license (New York 232194, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Tayyaba Riaz Bashir
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 232194 NY
Self-reported in NPPES; status is on the state search - Practice location
- 325 W 15TH St, New York, NY 10011
- Phone
- (212) 604-6011
- Enumerated
- Jun 8, 2007
- Record last updated
- Jul 8, 2007 (not updated in 19 years: call before relying on the address or phone)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 1,163 in New York → Look up another NPI →
Also registered at 325 W 15TH St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Michelle Abraham, LCSWClinical Social Worker1053959775
- Mollie Aidasani, NPWomen's Health Nurse Practitioner1467704296
- Christian Archer, MDHospice and Palliative Medicine (Family Medicine) Physician1548882707
- Arezo Aziz, DNP, FNP-BCFamily Nurse Practitioner1538841689
- Anthony Berson, M.D.Specialist1881691301
- Ivan Biglang Awa, NPAcute Care Nurse Practitioner1538803952
Verify Tayyaba Riaz Bashir in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 232194Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
90% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
92 Medicare Part D claims for 24 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 33% of claims.
Most prescribed
- Letrozole27 claims
- Tagrisso15 claims
- Hydroxyurea14 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $20.91
1 payment: food and beverage; the largest payer was E.R. Squibb & Sons, L.L.C. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Tayyaba Riaz Bashir among 1,163 hematology & oncology physician records in New York
Tayyaba Riaz Bashir, M.D. is one of 1,163 hematology & oncology physician records with a practice address in New York. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 47% of them.
- NPI issued2007 · 47% of these records are older, 44% newer
- In a Medicare fileYes · 83% of these records are
- In the CMS Doctors and Clinicians fileNo · 72% of these records are
- Record last updated2007 · 61% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in New York
There are 1,163 hematology & oncology physician records in New York.
All 1,163 in New York → Every provider in New York → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Neal Friedberg, M.D.New York, NY 100111639415995
- Ira Halperin, MDNew York, NY 100111437245321
- Paula Klein, M.D.New York, NY 100111568450781
- Bobby Liaw, M.D.New York, NY 100111851528731
- Shambavi Richard, M.D.,New York, NY 100111750323994
- Theresa Shao, MDNew York, NY 100111134399306
- Richard Hirschman, M.D.New York, NY 100101669524674
- Arthur Radin, M.D.New York, NY 100101396839510
Common questions
What is Tayyaba Riaz Bashir, M.D.'s NPI number?
Tayyaba Riaz Bashir, M.D.'s National Provider Identifier (NPI) is 1528261351, issued on Jun 8, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Tayyaba Riaz Bashir, M.D. located?
The NPPES record lists a practice address at 325 W 15TH St, New York, NY, 10011. Phone: (212) 604-6011. Providers update this record themselves, so call before visiting.
How can I verify Tayyaba Riaz Bashir, M.D.'s license?
NPPES lists New York license number 232194, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Tayyaba Riaz Bashir, M.D. prescribe under Medicare Part D?
In 2024, Tayyaba Riaz Bashir, M.D. had 92 Medicare Part D claims for 24 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.